Article

Cerebrospinal Fluid Myeloperoxidase Is Associated With Putamen Volume Beyond Neurofilament Light in Huntington's Disease

2026-08-31

Abstract excerpt

<h4>Background: </h4> The primary neuroanatomical site of Huntington-s disease (HD) pathology resides in the striatum and its atrophy identifies important disease progression from HD-ISS Stage 0 to Stage 1. Immune-associated proteins may capture variation in HD that is incompletely represented by markers of neuroaxonal injury. <h4>Objectives:</h4> To determine whether cerebrospinal-fluid myeloperoxidase contribute...

Identifiers and source

Literature Corpus work: 45070069-7d90-577d-ad7c-9d706fd2d524
DOI: 10.64898/2026.08.28.26361663

Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest

Cerebrospinal Fluid Myeloperoxidase Is Associated With Putamen Volume Beyond Neurofilament Light in Huntington's DiseaseDOI 10.64898/2026.08.28.26361663Read

A Two-Track Model of Striatal Degeneration in Huntington’s Disease: Independent Contributions of Cytoskeletal Damage and Immune Dysregulation Consistent with an Immune-Exhaustion-Like ProfileSemantic proximity Read

Comparisons of neurodegenerative disease biomarkers across different biological fluids from patients with Huntington’s diseaseSemantic proximity Read

Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington’s diseaseSemantic proximity Read

Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.Semantic proximity Read

Cerebrospinal Fluid Biomarkers for Huntington’s DiseaseSemantic proximity Read

Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?Semantic proximity Read

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysisSemantic proximity Read

Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington’s diseaseSemantic proximity Read

Longitudinal dynamics of mutant huntingtin and neurofilament light in Huntington’s disease: the prospective HD-CSF studySemantic proximity Read

Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseasesSemantic proximity Read

Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington’s disease patientsSemantic proximity Read

Plasma NfL as a prognostic biomarker for enriching HD-ISS stage 1 categorisation: a cross-sectional studySemantic proximity Read